Cervical cancer
Conditions
Interventions
Group of LRH incorporating MTF techniques:None
Group of Conventional LRH:None
Sponsors
Chinese Academy of Medical Sciences and Peking Union Medical College Peking Union Medical College Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Underwent operation performed by the three gynecologic oncologists (Y.X., J.Y., T.R.) between January 2017 to November 2021 at PUMCH; 2. Histologically diagnosed as squamous cell carcinoma (SCC), adenosquamous carcinoma (ASC), or adenocarcinoma (AC) of the cervix; 3. Preoperatively staged as IA2, IB1, IB2, IIA1 according to FIGO 2018 staging system; 4. Underwent laparoscopic radical hysterectomy (type C of the Querleu-Morrow classification), and sentinel lymph node dissection (SLN) or pelvic lymphadenectomy, with or without para-aortic lymphadenectomy.
Exclusion criteria
Exclusion criteria: 1. Neuroendocrine carcinoma or carcinosarcoma of the cervix at final pathology; 2. Underwent fertility-sparing surgery or modified radical hysterectomy (type B).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Complication;Time of operation;Blood loss;Hospital stay; | — |
Countries
China
Contacts
Public ContactYang Xiang
Peking Union Medical College Hospital
Outcome results
None listed